D. Christopher  Chung net worth and biography

D. Christopher Chung Biography and Net Worth

D. Christopher Chung joined Natus in 2000 as our Medical Director.  He has also served as Vice President of R&D and most recently since 2011 as our Vice President Medical Affairs, Quality and Regulatory.  From 2000 to 2007, Dr. Chung also served as a Pediatric Hospitalist at the California Pacific Medical Center in San Francisco providing patient care in the Neonatal Intensive Care Unit and Newborn Nursery.  From 1997 to 2000, Dr. Chung trained as a pediatric resident at Boston Children’s Hospital and Harvard Medical School.  From 1986 to 1993, Dr. Chung worked as an R&D engineer at Nellcor Incorporated, a medical device company that pioneered the development of pulse oximetry.  Dr. Chung holds a Bachelor of Arts degree in Computer Mathematics from the University of Pennsylvania and a Doctor of Medicine degree from the Medical College of Pennsylvania-Hahnemann University School of Medicine.  He is board certified in Pediatrics and is a Fellow of the American Academy of Pediatrics.  Dr. Chung has also been awarded nine US patents in the medical device field.

What is D. Christopher Chung's net worth?

The estimated net worth of D. Christopher Chung is at least $1.75 million as of June 1st, 2021. Dr. Chung owns 53,234 shares of Natus Medical stock worth more than $1,754,593 as of April 17th. This net worth approximation does not reflect any other investments that Dr. Chung may own. Learn More about D. Christopher Chung's net worth.

How do I contact D. Christopher Chung?

The corporate mailing address for Dr. Chung and other Natus Medical executives is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. Natus Medical can also be reached via phone at (608) 829-8500 and via email at [email protected]. Learn More on D. Christopher Chung's contact information.

Has D. Christopher Chung been buying or selling shares of Natus Medical?

D. Christopher Chung has not been actively trading shares of Natus Medical during the past quarter. Most recently, Dong Chune Christopher Chung sold 11,787 shares of the business's stock in a transaction on Thursday, December 9th. The shares were sold at an average price of $23.08, for a transaction totalling $272,043.96. Learn More on D. Christopher Chung's trading history.

Who are Natus Medical's active insiders?

Natus Medical's insider roster includes D. Christopher Chung (VP), and Alice Schroeder (Director). Learn More on Natus Medical's active insiders.

D. Christopher Chung Insider Trading History at Natus Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2021Sell11,787$23.08$272,043.96View SEC Filing Icon  
6/1/2021Sell12,500$27.55$344,375.0053,234View SEC Filing Icon  
5/27/2021Sell10,467$27.10$283,655.7053,234View SEC Filing Icon  
5/20/2021Sell9,290$27.00$250,830.00108,793View SEC Filing Icon  
5/18/2021Sell2,904$26.90$78,117.60108,793View SEC Filing Icon  
5/14/2021Sell21,927$28.31$620,753.37161,345View SEC Filing Icon  
5/12/2021Sell10,108$27.47$277,666.76161,345View SEC Filing Icon  
10/30/2019Sell14,000$33.67$471,380.00
See Full Table

D. Christopher Chung Buying and Selling Activity at Natus Medical

This chart shows Dong Chune Christopher Chung's buying and selling at Natus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Natus Medical Company Overview

Natus Medical logo
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.
Read More

Today's Range

Now: $32.96
Low: $32.96
High: $32.96

50 Day Range

MA: $32.96
Low: $32.96
High: $32.96

2 Week Range

Now: $32.96
Low: $20.90
High: $33.93

Volume

1,514 shs

Average Volume

325,002 shs

Market Capitalization

$1.14 billion

P/E Ratio

89.08

Dividend Yield

N/A

Beta

0.22